Literature DB >> 8720611

Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.

G Nijpels1, C Popp-Snijders, P J Kostense, L M Bouter, R J Heine.   

Abstract

The aims of the present study were to observe the natural history of impaired glucose tolerance and to identify predictors for development of non-insulin-dependent diabetes mellitus (NIDDM). A survey of glucose tolerance was conducted in subjects aged 50-74 years, randomly selected from the registry of the middle-sized town of Hoorn in the Netherlands. Based on the mean values of two oral glucose tolerance tests subjects were classified in categories of glucose tolerance according to the World Health Organization criteria. All subjects with impaired glucose tolerance (n = 224) were invited to participate in the present study, in which 70% (n = 158) were subsequently enrolled. During follow-up subjects underwent a repeated paired oral glucose tolerance test. The mean follow-up time was 24 months (range 12-36 months). The cumulative incidence of NIDDM was 28.5% (95% confidence interval 15-42%). Age, sex, and anthropometric and metabolic characteristics at baseline were analysed simultaneously as potential predictors of conversion to NIDDM using multiple logistic regression. The initial 2-h post-load plasma glucose levels and the fasting proinsulin levels were significantly (p < 0.05) related to the incidence of NIDDM. Anthropometric characteristics, the 2-h post-load specific insulin levels and the fasting proinsulin/fasting insulin ratio were not related to the incidence of NIDDM. These results suggest that beta-cell dysfunction rather than insulin resistance plays the most important role in the future development of diabetes in a high-risk Caucasian population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8720611     DOI: 10.1007/BF00400421

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans.

Authors:  S M Haffner; M P Stern; J Dunn; M Mobley; J Blackwell; R N Bergman
Journal:  Metabolism       Date:  1990-08       Impact factor: 8.694

2.  High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance.

Authors:  A A Motala; M A Omar; E Gouws
Journal:  Diabetes       Date:  1993-04       Impact factor: 9.461

3.  Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Z Zimmet; V R Collins; G K Dowse; L T Knight
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

4.  The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study.

Authors:  H King; P Zimmet; L R Raper; B Balkau
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

5.  Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.

Authors:  P M Clark; J C Levy; L Cox; M Burnett; R C Turner; C N Hales
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

6.  Comparison of three methods for the quantification of beta-cell function and insulin sensitivity.

Authors:  G Nijpels; P S van der Wal; L M Bouter; R J Heine
Journal:  Diabetes Res Clin Pract       Date:  1994-12-31       Impact factor: 5.602

7.  Physiological increase in plasma insulin concentration suppresses proinsulin secretion in normal controls but not in subjects with glucose intolerance.

Authors:  T Wasada; H Kuroki; H Arii; A Maruyama; S Saito; Y Watanabe; Y Omori
Journal:  Endocr J       Date:  1994-04       Impact factor: 2.349

8.  Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.

Authors:  M J Davies; G Rayman; I P Gray; J L Day; C N Hales
Journal:  Diabet Med       Date:  1993-05       Impact factor: 4.359

9.  Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type 2 diabetes mellitus.

Authors:  M J Davies; J Metcalfe; I P Gray; J L Day; C N Hales
Journal:  Diabet Med       Date:  1993-05       Impact factor: 4.359

10.  A two-step model for development of non-insulin-dependent diabetes.

Authors:  M F Saad; W C Knowler; D J Pettitt; R G Nelson; M A Charles; P H Bennett
Journal:  Am J Med       Date:  1991-02       Impact factor: 4.965

View more
  26 in total

1.  Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  R C Loopstra-Masters; S M Haffner; C Lorenzo; L E Wagenknecht; A J Hanley
Journal:  Diabetologia       Date:  2011-09-30       Impact factor: 10.122

2.  Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: a population-based study.

Authors:  L M Hart; R P Stolk; R J Heine; D E Grobbee; F E van der Does; J A Maassen
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study.

Authors:  Vera Schmid; Robert Wagner; Corinna Sailer; Louise Fritsche; Konstantinos Kantartzis; Andreas Peter; Martin Heni; Hans-Ulrich Häring; Norbert Stefan; Andreas Fritsche
Journal:  Diabetologia       Date:  2017-08-24       Impact factor: 10.122

4.  Exercise training and metformin, but not exercise training alone, decreases insulin production and increases insulin clearance in adults with prediabetes.

Authors:  Richard Viskochil; Steven K Malin; Jennifer M Blankenship; Barry Braun
Journal:  J Appl Physiol (1985)       Date:  2017-05-04

5.  Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.

Authors:  Andreas Pfützner; Iris Hermanns; Sanja Ramljak; Filiz Demircik; Anke H Pfützner; Peter H Kann; Matthias M Weber
Journal:  J Diabetes Sci Technol       Date:  2015-09-29

6.  Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin.

Authors:  Andreas Pfützner; Anke H Pfützner; Peter H Kann; Gunther Burgard
Journal:  J Diabetes Sci Technol       Date:  2016-09-25

Review 7.  Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone.

Authors:  Andreas Pfützner; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

8.  Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.

Authors:  H C Gerstein; S Yusuf; R Holman; J Bosch; J Pogue
Journal:  Diabetologia       Date:  2004-08-21       Impact factor: 10.122

Review 9.  A1C level and future risk of diabetes: a systematic review.

Authors:  Xuanping Zhang; Edward W Gregg; David F Williamson; Lawrence E Barker; William Thomas; Kai McKeever Bullard; Giuseppina Imperatore; Desmond E Williams; Ann L Albright
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

10.  Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2007-12-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.